Dispenser
Latest Bristol-Myers Squibb Company Patents:
- Substituted indole dimer compounds
- METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3
- Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
- Substituted thienopyrroles as PAD4 inhibitors
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
Description
Claims
We claim the ornamental design for the dispenser, as shown and described.
Referenced Cited
U.S. Patent Documents
D245891 | September 27, 1977 | Milbourne, Jr. |
4164306 | August 14, 1979 | Perrin |
D298097 | October 18, 1988 | Vogel et al. |
D444978 | July 17, 2001 | Kauzlarich et al. |
D449753 | October 30, 2001 | DeKoning et al. |
D452009 | December 11, 2001 | Huffman |
D467108 | December 17, 2002 | Ahlstrom et al. |
D529739 | October 10, 2006 | Bertucci et al. |
D530124 | October 17, 2006 | Ophardt et al. |
Patent History
Patent number: D547988
Type: Grant
Filed: Feb 27, 2006
Date of Patent: Aug 7, 2007
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Troy Baker (St. Asaph), Kelly Dawson (St. Asaph), Wyn Jones (St. Asaph)
Primary Examiner: Brian N Vinson
Attorney: John M. Kilcoyne
Application Number: 29/254,655
Type: Grant
Filed: Feb 27, 2006
Date of Patent: Aug 7, 2007
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Troy Baker (St. Asaph), Kelly Dawson (St. Asaph), Wyn Jones (St. Asaph)
Primary Examiner: Brian N Vinson
Attorney: John M. Kilcoyne
Application Number: 29/254,655
Classifications
Current U.S. Class:
D6/545